NASDAQ: GWPH       Gw Pharma ADR
Last Price Today's Change   Day's Range   Trading Volume
111.761   -2.749 (2.40%)  109.27 - 114.03  268,922


Avg Volume (4 weeks):662,005
4 Weeks Range:99.00 - 122.69
4 Weeks Price Volatility (%):
52 Weeks Range:95.71 - 196.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

GW Pharmaceuticals PLC is a UK based company, engaged in the research, development, and commercialization of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company’s lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

  Be the first to like this.


3517  2185  313  2954 

Top 10 Active Counters
 CELG 108.24+0.11 
 NIO 4.165-0.495 
 AVP 5.60-0.05 
 ACHN 6.865+0.735 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 CHK 0.537-0.021 
 AMD 49.46-0.89 
 F 8.925-0.075 
 ECA 3.79-0.25 
Partners & Brokers